These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4709191)

  • 1. Effectiveness of regressive ECT with process schizophrenia.
    Exner JE; Murillo LG
    Dis Nerv Syst; 1973 Jan; 34(1):44-8. PubMed ID: 4709191
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK; Ungvari GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of regressive ECT with process schizophrenics.
    Murillo LG; Exner JE
    Am J Psychiatry; 1973 Mar; 130(3):269-73. PubMed ID: 4143944
    [No Abstract]   [Full Text] [Related]  

  • 4. Schizophrenic patients treated with electroconvulsive therapy: their demographic, clinical and cognitive features.
    Gureje O
    East Afr Med J; 1988 Jun; 65(6):379-86. PubMed ID: 3181059
    [No Abstract]   [Full Text] [Related]  

  • 5. Seizure activity in combined clozapine and ECT: a retrospective view.
    Cardwell BA; Nakai B
    Convuls Ther; 1995 Jun; 11(2):110-3. PubMed ID: 7552049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
    Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
    J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
    [No Abstract]   [Full Text] [Related]  

  • 7. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
    Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
    East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy.
    Nahshoni E; Manor N; Bar F; Stryjer R; Zalsman G; Weizman A
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):121-5. PubMed ID: 15013027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
    Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
    J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance ECT in schizophrenia: a pilot study.
    Chanpattana W
    J Med Assoc Thai; 1998 Jan; 81(1):17-24. PubMed ID: 9470317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of electroconvulsive therapy and the length of stay of psychiatric inpatients at King Chulalongkorn Memorial Hospital, Thai Red Cross Society.
    Lalitanatpong D
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S142-8. PubMed ID: 16623019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute schizophrenia: the place of ECT.
    Sullivan PR
    Dis Nerv Syst; 1974 Oct; 35(10):467-9. PubMed ID: 17894060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Paul H. Hoch Award Lecture: a followup study of the results of treatment of schizophrenia.
    May PR; Tuma AH
    Proc Annu Meet Am Psychopathol Assoc; 1976; (64):256-84. PubMed ID: 946683
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuation electroconvulsive therapy in schizophrenia: a pilot study.
    Chanpattana W
    J Med Assoc Thai; 1997 May; 80(5):311-8. PubMed ID: 9175375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia.
    Chanpattana W; Chakrabhand ML; Kitaroonchai W; Choovanichvong S; Prasertsuk Y
    J Med Assoc Thai; 1999 May; 82(5):477-83. PubMed ID: 10443097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusting the frequency of continuation and maintenance electroconvulsive therapy to prevent relapse of catatonic schizophrenia in middle-aged and elderly patients who are relapse-prone.
    Suzuki K; Awata S; Takano T; Ebina Y; Shindo T; Harada N; Matsuoka H
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):486-92. PubMed ID: 16884452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships.
    Clark ML; Ramsey HR; Rahhal DK; Serafetinides EA; Wood FD; Costiloe JP
    Arch Gen Psychiatry; 1972 Oct; 27(4):479-83. PubMed ID: 5072717
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance ECT in treatment-resistant schizophrenia.
    Chanpattana W
    J Med Assoc Thai; 2000 Jun; 83(6):657-62. PubMed ID: 10932493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.